12:06
MEI Pharma announced the acquisition of 929,548 LTC, with a total value of approximately 110 million USD.
Golden Finance reports that MEI Pharma has announced the acquisition of 929,548 Litecoins (LTC), with an average purchase price of $107.58, totaling approximately $110 million. The company becomes the first publicly listed company in the United States to use Litecoin as a primary reserve asset.
In addition, MEI Pharma has launched a $100 million institutional treasury strategy in collaboration with Litecoin founder Charlie Lee and GSR.
LTC0.61%